CXCL12 and pulmonary arterial hypertension: The present study showed that baicalin was effective in reducing RVSP, right ventricular hypertrophy, SDF-1/CXCR4 expression and PI3K/AKT pathway activation in PAH, thereby partially reversing pulmonary vascular remodeling.